SC 13G

Company

Inhibikase Therapeutics, Inc.

Filed

March 23, 2021

Accession Number

0001104659-21-040191

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →